IMARC Group, a leading market research company, has recently releases report titled “In-vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” the global in vivo CRO market size reached US$ 4.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.07% during 2023-2028.
In-vivo contract research organization (CRO) is a specialized entity that can carry out experiments within a living organism to collect valuable data and insights. It includes several scientific disciplines, such as pharmacology, toxicology, and physiology. It enables researchers to evaluate the safety, efficacy, and potential risks of new drugs or medical treatments. It helps medical science progress by providing vital information required for regulatory approvals. It improves healthcare services by fastening the process of developing novel medications and treatments. It lessens the need for considerable internal resources, such as staff and infrastructure, and reduces expenses related to drug development. It is consequently utilized by pharmaceutical companies, biotechnology firms, and academic research institutions around the world.
Request a free sample brochure: https://www.imarcgroup.com/in-vivo-cro-market/requestsample
In-vivo CRO Market Trends and Drivers:
At present, increasing advancements in research technologies and methodologies to enhance the capabilities of in-vivo CROs represent one of the key factors impelling the market growth. Additionally, the growing focus on pharmaceutical and biotechnological research, coupled with the development of novel drugs and therapies, is necessitating the utilization of in-vivo CRO services. Besides this, there is a rise in the employment of in-vivo CROs to provide specialized knowledge and state-of-the-art facilities, which ensure high-quality research outcomes and reduces the risk of experimental errors. Moreover, the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, among individuals is catalyzing the demand for drug discovery and development wherein in vivo studies are pivotal. In addition, the growing integration of data analytics and artificial intelligence (AI) in in-vivo research to improve data interpretation and predictive modeling is positively influencing the market. Furthermore, the escalating demand for biosimilars, which are highly similar versions of approved biologic drugs, is leading to the rising adoption of in-vivo studies to demonstrate their safety and efficacy. Apart from this, there is an increasing digital transformation of healthcare procedures by using electronic health records (EHRs) and telemedicine, which are generating vast amounts of data that can be leveraged in in-vivo research for insights into patient outcomes.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Charles River Laboratories International Inc.
- Evotec SE
- ICON plc
- Iris Pharma (Abionyx Pharma)
- Labcorp Drug Development (Laboratory Corporation of America Holdings)
- North American Science Associates LLC
- Parexel International Corporation
- Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.)
- Pronexus Analytical AB
- Syneos Health and WuXi AppTec.
The report has been segmented the market into following categories:
Breakup by Type:
- Rodent
- Rats
- Mice
- Others
- Non-Rodent
Breakup by GLP Type:
- Non-GLP
- In House
- Outsourcing
- GLP Toxicology
- In House
- Outsourcing
Breakup by Indication:
- Autoimmune/Inflammation Conditions
- Rheumatoid Arthritis
- Multiple Sclerosis
- Osteoarthritis
- Irritable Bowel Syndrome
- Others
- Pain Management
- Chronic Pain
- Acute Pain
- Oncology
- Blood Cancer
- Solid Tumor
- Others
- CNS Conditions
- Epilepsy
- Parkinson’s Disease
- Huntington’s Disease
- Stroke
- Traumatic Brain Injury
- ALS
- Muscle Regeneration
- Others
- Diabetes
- Obesity
- Others
By Geography:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800